PROSTATE CANCER RATE HIGH AMONG BAY AREA BLACKSAssociated Press
Golden Gate Urology is a skilled San Francisco Urologists Bay Area * Prostate Cancer Doctors Berkeley, Oakland, Daly City California. Accepting new appointments. Call today or request an appointment on our website.
LATEST NEWS AND RESEARCH ON PROSTATE CANCER Increase your personal odds of survival by empowering yourself with the latest research and news on prostate cancer; 'news you can use' today and incorporate into your Integrative treatment programme to increase your personal odds of survival. Below you...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a label extension for XTANDI™ (enzalutamide) as monotherapy or in combination with androgen deprivat...
This Clinical Policy Bulletin addresses ablative procedures for prostate cancer.Experimental, Investigational, or Unproven Aetna considers the following ablative procedures experimental, investigational, or unproven for the treatment (primary or salvage therapy) of prostate cancer because their effectiveness has...
Bone-targeting agents in prostate cancer Daniel L. Suzman Sosipatros A. Boikos Michael A. Carducci Cancer and Metastasis Reviews (2014) Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: Focus on Non-Chemotherapy Agents Julie N. Graff Tomasz M. ...
17, 18, 19 Recent successful detection of GRPR-expressing prostate cancer in clinical studies using RM26 derivatives (68Ga-BAY86-754820 and 64Cu-CB-TE2A-AR0621) further demonstrated the potential usefulness of radiolabeled GRPR antagonists for prostate cancer imaging. Among commercially available ...
(BiTE) therapies have demonstrated clinical benefit in hematologic malignancies, their application to solid tumors has been an active area of investigation. However, in prostate cancer, due to the heterogeneous and immune-suppressive tumor microenvironment, the development of immunotherapy strategies remains...
prostate-specific membrane antigen (PSMA);nanocarriers;nanoparticle;enhanced permeability and retention (EPR) effect;small-molecule PSMA inhibitors;prostate cancer theranostics;radioligand theranostics;radiopharmaceutical therapy;positron emission tomography (PET) ...
sensors Review Multiplexed Prostate Cancer Companion Diagnostic Devices Josephine Aidoo-Brown, Despina Moschou and Pedro Estrela * Centre for Biosensors, Bioelectronics and Biodevices (C3Bio), Department of Electronic & Electrical Engineering, University of Bath, Claverton Down, Bath BA2 7AY, UK; jga...